Biotechnology company Denali Therapeutics Inc. (DNLI) has garnered our attention with its innovative approach to tackling neurodegenerative and lysosomal storage diseases. The company is building a diverse pipeline of therapies that aim to cross the blood-brain barrier, one of the most significant challenges in modern medicine.
With programs advancing in rare genetic disorders such as Hunter syndrome and Sanfilippo syndrome, alongside broader indications like Alzheimer's and Parkinson's disease, the South San Francisco, California-based company is positioning itself at the forefront of neurological drug development.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.